Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q2 2021 · 10-Q
Revenue$52.96M$52.96M+334.7% vs Q2 2020 Net Income-$13.09M-$13.09MN/M vs Q2 2020 EPS Diluted-$0.48-$0.48N/M vs Q2 2020 Gross Profit$45,441,000+344.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$10,114,000N/M Free Cash Flowderived-$11,777,000N/M Margins · derivedGross margin85.8%+1.8 pt vs Q2 2020
Operating margin-23.7%+163.6 pt vs Q2 2020
Net margin-24.7%+164.8 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 3, 2021 · 34 d after period end